B of A Securities Upgrades Cellebrite DI to Buy, Announces $12 Price Target
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Tomer Zilberman has upgraded Cellebrite DI (NASDAQ:CLBT) from Neutral to Buy and set a price target of $12. This upgrade reflects a positive outlook on the company's future performance.
February 16, 2024 | 12:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cellebrite DI has been upgraded from Neutral to Buy by B of A Securities, with a new price target of $12.
The upgrade from Neutral to Buy by a significant analyst at B of A Securities, along with a specific price target of $12, indicates a strong positive sentiment towards Cellebrite DI's stock. This is likely to influence investor perception positively in the short term, leading to potential price appreciation.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100